LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 99 filers reported holding LYELL IMMUNOPHARMA INC in Q1 2023. The put-call ratio across all filers is 3.20 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,488 | -53.8% | 20,740 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $65,953 | +34.7% | 20,740 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $48,946 | -32.0% | 20,740 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $71,968 | -52.7% | 20,740 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $152,000 | -85.1% | 20,740 | -89.7% | 0.00% | -88.2% |
| Q1 2022 | $1,019,000 | -34.8% | 201,793 | 0.0% | 0.02% | -22.7% |
| Q4 2021 | $1,562,000 | -48.7% | 201,793 | -2.0% | 0.02% | -56.0% |
| Q3 2021 | $3,047,000 | -62.4% | 205,870 | -58.8% | 0.05% | -66.9% |
| Q2 2021 | $8,113,000 | – | 499,559 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $47,583,104 | 33.50% |
| Orland Properties Ltd | 15,093,969 | $35,621,767 | 18.69% |
| Foresite Capital Management IV, LLC | 10,000,000 | $23,600,000 | 12.24% |
| MIC Capital Management UK LLP | 3,060,569 | $7,222,943 | 1.38% |
| Alphabet Inc. | 5,865,125 | $13,841,695 | 0.77% |
| HSG Holding Ltd | 3,045,997 | $7,188,553 | 0.76% |
| XTX Topco Ltd | 286,614 | $676,409 | 0.14% |
| Eagle Health Investments LP | 100,000 | $236,000 | 0.05% |
| BBR PARTNERS, LLC | 164,041 | $387,137 | 0.04% |
| CORNERCAP INVESTMENT COUNSEL INC | 90,172 | $212,806 | 0.04% |